HIRSCHMAN ORIN 13D and 13G filings for Annovis Bio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-28 4:05 pm Sale | 2023-11-28 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 470,000 4.580% | -103,941 (-18.11%) | Filing |
| 2023-11-08 07:02 am Purchase | 2023-10-31 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 573,941 5.600% | 245,583 (+74.79%) | Filing |
| 2021-01-28 07:49 am Sale | 2021-01-21 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 328,358 4.760% | -170,439 (-34.17%) | Filing |
| 2020-07-21 08:03 am Purchase | 2020-07-10 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 498,797 7.270% | 175,507 (+54.29%) | Filing |
| 2020-07-10 4:20 pm Sale | 2020-07-07 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 323,290 4.740% | -191,710 (-37.23%) | Filing |
| 2020-01-30 2:52 pm Purchase | 2020-01-29 | 13G | Annovis Bio, Inc. ANVS | HIRSCHMAN ORIN | 515,000 7.900% | 515,000 (New Position) | Filing |